Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Those share trades for yesterday show some insty is accumulating a nice big wedge. 162k and 65k followed by some other nice chunks suggest our bottom is in. This works out perfectly just before CF hits the presentation road.
The sells are taking us down but they are not huge. MM's working the orders.
However, with buying like this now recorded we should spring back in pretty short order.
Hello Indiscipline
If you get time could you look at this - its a PMI / Healthcare Industry bulletin / news mail.
My only opinion in this post is that if AVIVA are maintaining this stance currently then so will BUPA / AXA etc - Happy to be told otherwise.
https://www.healthinsuranceandprotection.com/covid-19/aviva-uk-healths-dr-subashini-mm-testing-times-%e2%80%93-antibody-tests-and-pmi?utm_source=Adestra&utm_medium=email&utm_term=&utm_content=Aviva%20UK%20Health%E2%80%99s%20Dr%20Subashini%20M%3A%20Testing%20times%20%E2%80%93%20antibody%20tests%20and%20PMI&utm_campaign=News%2020.07.07A&user_id=&tracker_id=
From OO website:
https://www.openorphan.com/sites/openorphan-v2/files/hVIVO%20COVID%20Clear.pdf
Corporate's want to get people back to work (I work in the City there is a huge demand as home working while a good thing and will change working forever - is not ideal eg Lloyd's broking / stock exchange etc etc)
PMI providers want the gold standard test according to the article - or they will not pay ?
PMI is standard contract benefit for most of the financial sector employees in the City and Canary Wharf and they are keen to use this benefit - as they see it as no-brainer rather than NHS etc - no view on this myself.
OO is based in Whitchapel and are recruiting / and indeed have a team of AHP's to collect bloods from Corp's already.
Occupational Health will want the most accurate testing - or they will be under great scrutiny - IMO
You sound like someone to give a balanced answer and I would be interested to hear your thoughts.
I hold AVCT as well - for different reasons but my faith in CL has resulted in an unbalanced portfolio - in favor of OO - RAMP ALERT yawn
GLA
In essence the antibody element of the testing is what Cathal has been highlighting and its importance.
We cover as the various articles in the media have highlighted the test for whether you have the virus and the check
for whether you have had the virus.
How it relates with the insurance companies may be fluid in this regard. At this stage we do not know for sure how long the antibodies last after having had the virus is it only months or a year or two. There have been arguments in this area.
The shorter it is the better for us as the need for testing people who have had the virus increases.
Companies need to test no matter what the insurance aspects. Professional firms will have highly paid professionals who if forced into the office can will their ar5e5 off them if put in unnnecessary danger.
Either way testing for firms in Finance and the Law will kick in. We are it seems going up against Honeyman group but, from what CF said, in interviews, talks with Corporates appeared fruitful. There should be plenty to go round.
I would back CF to deliver in this area. With one thousand a day you are looking at around £24 million in revenue with say around half hitting the bottom line. That alone can kick up the stock price.
In previous answer highly paid Professionals will sue the ar5e off the company if they are sent in without adequate testing and cover. All apologies for poor explanation.
still no comment on the crowd in Barnard Castle offering Quotient testing is spite of our "exclusivity?"
maybe we can blame Dominic Cummings...he knows the area well I'm told...
This tells today story...
# of Trades 204
Vol Sold 1,069,096
Vol Bought 2,382,517
The share price dropped 1,30%.
How are the figures meaningless?
Nowt.. they can be meaningless because there is an over reliance on the buys / sells being reported accurately when there are so many delayed reported trades given they exceed the EMS (exchange market size) and the Spread can be out of kilter with the actual trade price. Below is a simple example of a late printed sell from the 6th being reported as a buy on the 7th.
You have to be very cautious with live pricing and printed trades as often, all is not what it appears. Lots of orders run behind the scenes and the only real gauge is the actual SP..
06-Jul-20 09:44:55 11.55 1,401,964 Buy* 11.20 11.50 161.93k